SCN9A variant and dysautonomia

Hoopoe

Senior Member (Voting Rights)
A clinical geneticist believes that a rare variant in the SCN9A gene could be responsible for at least a part of my symptoms. The variant is extremely rare (1 in 1.4 million alleles) and not found in healthy people.

Nav1.7 is a sodium ion channel that in humans is encoded by the SCN9A gene. It is usually expressed at high levels in two types of neurons: the nociceptive (pain) neurons at dorsal root ganglion (DRG) and trigeminal ganglion and sympathetic ganglion neurons, which are part of the autonomic (involuntary) nervous system.

The gene is associated with small fibre neuropathy which would fit, but there is also an apparently hereditory orthostatic intolerance which is giving me some doubts because SCN9A is usually mentioned in the context of pain rather than orthostatic intolerance. Can we construct a credible narrative where a SCN9A variant is mostly causing orthostatic intolerance and some dysautonomia?
 
Curious to know if you get anywhere with this, especially as from memory we have an awful lot of symptom overlap. Have you had the genetic testing to confirm this mutation already?

After diagnosing SFN my neurologist suggested sending me to a sodium channel mutation expert. In his words I was somewhat of an anomaly and unlike his hundreds of other patients with SFN/dysautonomia. I think said expert was Prof David Bennett in Oxford.

Unfortunately my neurologist ended up on long-term sick and I was discharged from his clinic :thumbsdown:
 
I’m awaiting my results for sodium channel mutations which has taken nearly 2 years to come back due to a paperwork mix up.

I’m not sure how it would fit with dysautonomia. I share both that and severe widespread pain.

Have you had any response to sodium channel blockers? I haven’t.
 
In the present study, we demonstrate that smooth muscle cells of cutaneous arterioles and arteriole-venule shunts (AVS) in the skin express sodium channel Nav1.7.

https://pubmed.ncbi.nlm.nih.gov/25957174/

It sounds like it might be relevant.

Nav1.7 is also expressed in the hypothalamus where, among other things, it's involved in the release of vasopressin which is relevant to orthostatic intollerance.
 
Last edited:
Back
Top Bottom